1. Home
  2. FORD vs BTAI Comparison

FORD vs BTAI Comparison

Compare FORD & BTAI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • FORD
  • BTAI
  • Stock Information
  • Founded
  • FORD 1961
  • BTAI 2017
  • Country
  • FORD United States
  • BTAI United States
  • Employees
  • FORD N/A
  • BTAI N/A
  • Industry
  • FORD Plastic Products
  • BTAI Biotechnology: Pharmaceutical Preparations
  • Sector
  • FORD Industrials
  • BTAI Health Care
  • Exchange
  • FORD Nasdaq
  • BTAI Nasdaq
  • Market Cap
  • FORD 8.2M
  • BTAI 8.3M
  • IPO Year
  • FORD 1995
  • BTAI 2018
  • Fundamental
  • Price
  • FORD $13.68
  • BTAI $3.46
  • Analyst Decision
  • FORD
  • BTAI Buy
  • Analyst Count
  • FORD 0
  • BTAI 5
  • Target Price
  • FORD N/A
  • BTAI $34.80
  • AVG Volume (30 Days)
  • FORD 27.8K
  • BTAI 14.2M
  • Earning Date
  • FORD 08-13-2025
  • BTAI 08-15-2025
  • Dividend Yield
  • FORD N/A
  • BTAI N/A
  • EPS Growth
  • FORD N/A
  • BTAI N/A
  • EPS
  • FORD N/A
  • BTAI N/A
  • Revenue
  • FORD $27,729,913.00
  • BTAI $1,852,000.00
  • Revenue This Year
  • FORD N/A
  • BTAI N/A
  • Revenue Next Year
  • FORD N/A
  • BTAI $328.13
  • P/E Ratio
  • FORD N/A
  • BTAI N/A
  • Revenue Growth
  • FORD 1.17
  • BTAI 5.47
  • 52 Week Low
  • FORD $3.10
  • BTAI $1.17
  • 52 Week High
  • FORD $13.48
  • BTAI $16.64
  • Technical
  • Relative Strength Index (RSI)
  • FORD 79.43
  • BTAI 78.60
  • Support Level
  • FORD $10.70
  • BTAI $1.30
  • Resistance Level
  • FORD $13.09
  • BTAI $3.84
  • Average True Range (ATR)
  • FORD 0.98
  • BTAI 0.43
  • MACD
  • FORD 0.26
  • BTAI 0.19
  • Stochastic Oscillator
  • FORD 100.00
  • BTAI 85.04

About FORD Forward Industries Inc.

Forward Industries Inc is a provider of carrying and protective solutions. The company designs and distributes product protection for handheld electronic devices. Forward Industries sells soft-sided carrying cases for blood glucose diagnostic kits and portable consumer electronic devices such as tablets, personal computers, barcode Scanners, GPS devices, and others. The company operates in two segments, the OEM distribution segment sources and distributes carrying cases and other accessories for medical monitoring and diagnostic kits and a variety of other portable electronic and non-electronic devices directly to OEMs; The design segment, provides a full spectrum of hardware and software product design and engineering services. The majority of revenue is generated from the Design segment.

About BTAI BioXcel Therapeutics Inc.

BioXcel Therapeutics Inc is a clinical-stage biopharmaceutical company. The company is focused on drug development utilizing novel artificial intelligence (AI) to identify the next wave of medicines across neuroscience and immuno-oncology. The pipeline products of the company are BXCL501 and BXCL701. The company's commercial product, IGALMI (developed as BXCL501) is a proprietary, sublingual film formulation of dexmedetomidine approved by the FDA for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder in adults.

Share on Social Networks: